trial · primary record
AZD2693
Nonalcoholic Steatohepatitis
| Phase | Phase 2 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 220 |
| Primary completion | 2025-09-29 |
| Primary endpoint | Proportion of Participants Achieving NASH Resolution Without Worsening of Fibrosis Based on Histology After 52 Weeks of Treatment |
| Registry ID | NCT05809934 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:53.750Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05809934
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.